Annual Retained Earnings
-$617.02 M
-$62.26 M-11.22%
December 31, 2023
Summary
- As of February 22, 2025, XERS annual retained earnings is -$617.02 million, with the most recent change of -$62.26 million (-11.22%) on December 31, 2023.
- During the last 3 years, XERS annual retained earnings has fallen by -$279.64 million (-82.88%).
- XERS annual retained earnings is now -1713.13% below its all-time high of -$34.03 million, reached on December 31, 2016.
Performance
XERS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$666.75 M
-$15.74 M-2.42%
September 30, 2024
Summary
- As of February 22, 2025, XERS quarterly retained earnings is -$666.75 million, with the most recent change of -$15.74 million (-2.42%) on September 30, 2024.
- Over the past year, XERS quarterly retained earnings has dropped by -$63.11 million (-10.46%).
- XERS quarterly retained earnings is now -1000.52% below its all-time high of -$60.59 million, reached on December 31, 2017.
Performance
XERS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
XERS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -10.5% |
| 3 y3 years | -82.9% | -10.5% |
| 5 y5 years | -411.4% | -10.5% |
XERS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.1% | at low | -44.9% | at low |
| 5 y | 5-year | -150.6% | at low | -170.8% | at low |
| alltime | all time | -1713.1% | at low | -1000.5% | at low |
Xeris Biopharma Holdings Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$666.75 M(+2.4%) |
| Jun 2024 | - | -$651.01 M(+2.4%) |
| Mar 2024 | - | -$636.00 M(+3.1%) |
| Dec 2023 | -$617.02 M(+11.2%) | -$617.02 M(+2.2%) |
| Sep 2023 | - | -$603.63 M(+2.1%) |
| Jun 2023 | - | -$591.45 M(+3.5%) |
| Mar 2023 | - | -$571.60 M(+3.0%) |
| Dec 2022 | -$554.77 M(+20.6%) | -$554.77 M(+2.4%) |
| Sep 2022 | - | -$541.84 M(+4.2%) |
| Jun 2022 | - | -$520.01 M(+5.3%) |
| Mar 2022 | - | -$493.82 M(+7.3%) |
| Dec 2021 | -$460.11 M | -$460.11 M(+12.4%) |
| Sep 2021 | - | -$409.32 M(+6.8%) |
| Jun 2021 | - | -$383.31 M(+7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -$355.80 M(+5.5%) |
| Dec 2020 | -$337.38 M(+37.0%) | -$337.38 M(+6.9%) |
| Sep 2020 | - | -$315.53 M(+5.3%) |
| Jun 2020 | - | -$299.53 M(+8.7%) |
| Mar 2020 | - | -$275.43 M(+11.9%) |
| Dec 2019 | -$246.25 M(+104.1%) | -$246.25 M(+15.5%) |
| Sep 2019 | - | -$213.16 M(+18.2%) |
| Jun 2019 | - | -$180.33 M(+23.6%) |
| Mar 2019 | - | -$145.94 M(+20.9%) |
| Dec 2018 | -$120.67 M(+99.2%) | -$120.67 M(+20.4%) |
| Sep 2018 | - | -$100.25 M(+17.3%) |
| Jun 2018 | - | -$85.48 M(+17.9%) |
| Mar 2018 | - | -$72.49 M(+19.7%) |
| Dec 2017 | -$60.59 M(+78.0%) | -$60.59 M |
| Dec 2016 | -$34.03 M | - |
FAQ
- What is Xeris Biopharma Holdings annual retained earnings?
- What is the all time high annual retained earnings for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual retained earnings year-on-year change?
- What is Xeris Biopharma Holdings quarterly retained earnings?
- What is the all time high quarterly retained earnings for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly retained earnings year-on-year change?
What is Xeris Biopharma Holdings annual retained earnings?
The current annual retained earnings of XERS is -$617.02 M
What is the all time high annual retained earnings for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual retained earnings is -$34.03 M
What is Xeris Biopharma Holdings annual retained earnings year-on-year change?
Over the past year, XERS annual retained earnings has changed by -$62.26 M (-11.22%)
What is Xeris Biopharma Holdings quarterly retained earnings?
The current quarterly retained earnings of XERS is -$666.75 M
What is the all time high quarterly retained earnings for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly retained earnings is -$60.59 M
What is Xeris Biopharma Holdings quarterly retained earnings year-on-year change?
Over the past year, XERS quarterly retained earnings has changed by -$63.11 M (-10.46%)